Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about ISU ABXIS aggregated by PharmaCompass.com.

    Client Virtual Booth

    ISU ABXIS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    ISU ABXIS
    korearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    5th fl. Global R&D Center Building C, 22 Daewangpangyoro 712-beongil, Bundang-gu, Seongnam-si, Gyeonggi-do
    Telephone
    Telephone
    +82-31-696-4700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.abxis.com/eng/index.jsp
    Linkedin
    Linkedin
    https://www.linkedin.com/company/isu-abxis-co.-ltd
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Eucure Announces Partnership with ISU ABXIS for Tri-specific Antibodies
    Eucure Announces Partnership with ISU ABXIS for Tri-specific Antibodies

    https://www.businesswire.com/news/home/20221031005342/en

    BUSINESSWIRE
    31 Oct 2022
    Share Share
    Euho & ISU ABXIS to develop trispecific antibodies based on YH003 sequence
    Euho & ISU ABXIS to develop trispecific antibodies based on YH003 sequence

    https://www.businesswire.com/news/home/20221031005342/en/Eucure-Biopharma-a-Subsidiary-of-Biocytogen-Announces-Partnership-with-ISU-ABXIS-for-the-Development-of-Tri-specific-Antibodies-using-YH003-Antibody-Sequence

    BUSINESSWIRE
    31 Oct 2022
    Share Share
    Isu Abxis “expects 100% exclusive treatment for Gaucher disease in Algeria”
    Isu Abxis “expects 100% exclusive treatment for Gaucher disease in Algeria”

    https://www.pharmacompass.com/pdf/news/isu-abxis-ranked-first-for-two-consecutive-years-in-the-algerian-gaucher-disease-treatment-bidding-35378.pdf

    PRESS RELEASE
    12 Oct 2022
    Share Share
    Isu Abxis, ranked first for two consecutive years in the Algerian Gaucher disease treatment bidding
    Isu Abxis, ranked first for two consecutive years in the Algerian Gaucher disease treatment bidding

    https://www.pharmacompass.com/pdf/news/isu-abxis-ranked-first-for-two-consecutive-years-in-the-algerian-gaucher-disease-treatment-bidding-79217.pdf

    PRESS RELEASE
    26 Aug 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    fermion-oy-2024-05-13

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search